R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

Clinical trial NCT06398418 · RECRUITING

Trial details

NCT number: NCT06398418
Sponsor: Rise Therapeutics LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Solid Tumor Melanoma Basal Cell Cancer Squamous Cell Cancer Adenoma

Start date: 2025-08-01
Primary completion: 2027-04-30
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.